Bimekizumab Survey


The Canadian Association of Psoriasis Patients (CAPP) and the Canadian Psoriasis Network (CPN) are working together to tell decision makers more about psoriasis and experiences with bimekizumab for the treatment of moderate to severe plaque psoriasis.

We are using this information from you to provide patient input about psoriasis and bimekizumab.